Novo Nordisk says diabetes drug approved in Japan
COPENHAGEN (Reuters) – Denmark’s Novo Nordisk A/S, the world’s biggest insulin producer, said on Friday its diabetes treatment Tresiba had been approved in Japan. Novo Nordisk said in a statement it expected to launch Tresiba in the country as soon as price negotiations have been completed. (Reporting by Copenhagen Newsroom; Editing by Matt Driskill)
View full post on Health News Headlines – Yahoo! News
Leave a Reply